MENU
Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Sep 10, 2023

Stay Profitable in Volatile Markets: Tickeron's Best Robot of the Week Delivers 59% Annualized Return and 1.7 Sharpe Ratio!

We can all agree that the past week has been a rollercoaster ride for traders. With major US stock market indexes experiencing drops ranging from -0.71 percent to -3.63 percent, it's clear that navigating market turbulence demands a sophisticated trading approach. That's why we're excited to introduce Tickeron's best-performing algorithm of the week, a true beacon of stability and consistent results.

Swing Trader: Medium Volatility Stocks for Active Trading (TA&FA)

Click to view full description and closed trades for free!

In times of sharp corrections like these, the ability to accurately assess market volatility and manage risks effectively becomes paramount. Tickeron's cutting-edge algorithm is precisely crafted to do just that, offering you the confidence you need in today's challenging trading environment.

What sets our top robot apart is its remarkable Sharpe ratio of 1.7, a testament to its ability to deliver consistent returns while efficiently managing risk. This stability and reliability are what every trader seeks, especially in unpredictable markets.

Click to view full description and closed trades for free!

Key highlights of Tickeron's top-performing algorithm:

  1. Stability and Consistency: This AI robot is tailor-made for traders who prefer stocks with medium volatility while aiming to avoid significant drawdowns during downtrends. How does it achieve this feat? By utilizing a well-crafted arsenal of technical indicators focused on identifying uptrend reversal points. This balanced approach enables the robot to navigate both short and long positions skillfully, reducing the risk of prolonged drawdowns.
  2. Precise Risk Management: What sets our robot apart is its proprietary method, developed by our team of quantitative analysts, which assesses the strength and quality of momentum in the most active stocks within the US market. Using a complex algorithm, this process involves a pool of technical indicators, meticulously analyzed through neural networks, to determine precise entry points for positions.
  3. Proven Results: Backed by a high Sharpe ratio of 1.7, our algorithm consistently delivers impressive results.

Navigating the market's ups and downs requires a trusted companion by your side, and Tickeron's algorithm is that reliable partner. It excels in identifying opportunities while protecting your investments, allowing you to focus on your trading strategies without the anxiety of market volatility.

Stay ahead of market turbulence with Tickeron - your path to stability and consistent results!

Here are the latest trades:

Related Ticker: SAVA, PHUN, BLNK, ACAD

SAVA's RSI Indicator ascends from oversold territory

The RSI Indicator for SAVA moved out of oversold territory on November 21, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 31 similar instances when the indicator left oversold territory. In of the 31 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 26, 2025. You may want to consider a long position or call options on SAVA as a result. In of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for SAVA just turned positive on November 25, 2025. Looking at past instances where SAVA's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where SAVA advanced for three days, in of 258 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

SAVA moved below its 50-day moving average on November 28, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for SAVA crossed bearishly below the 50-day moving average on November 11, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SAVA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

SAVA broke above its upper Bollinger Band on November 26, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for SAVA entered a downward trend on November 28, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.925) is normal, around the industry mean (27.316). P/E Ratio (0.000) is within average values for comparable stocks, (52.494). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.898). Dividend Yield (0.000) settles around the average of (0.048) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (323.945).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SAVA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SAVA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

Notable companies

The most notable companies in this group are Regeneron Pharmaceuticals (NASDAQ:REGN), Incyte Corp (NASDAQ:INCY), Exelixis (NASDAQ:EXEL), Moderna (NASDAQ:MRNA), Arrowhead Pharmaceuticals (NASDAQ:ARWR), Adaptive Biotechnologies Corp (NASDAQ:ADPT), Sarepta Therapeutics (NASDAQ:SRPT), Nektar Therapeutics (NASDAQ:NKTR), Novavax (NASDAQ:NVAX), Inovio Pharmaceuticals (NASDAQ:INO).

Industry description

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

Market Cap

The average market capitalization across the Biotechnology Industry is 2.22B. The market cap for tickers in the group ranges from 58 to 110.02B. VRTX holds the highest valuation in this group at 110.02B. The lowest valued company is SEELQ at 58.

High and low price notable news

The average weekly price growth across all stocks in the Biotechnology Industry was 7%. For the same Industry, the average monthly price growth was 1%, and the average quarterly price growth was 73%. KTTA experienced the highest price growth at 403%, while CLSD experienced the biggest fall at -85%.

Volume

The average weekly volume growth across all stocks in the Biotechnology Industry was -34%. For the same stocks of the Industry, the average monthly volume growth was -60% and the average quarterly volume growth was -17%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 79
Price Growth Rating: 55
SMR Rating: 91
Profit Risk Rating: 93
Seasonality Score: 5 (-100 ... +100)
View a ticker or compare two or three
SAVA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. SAVA showed earnings on March 03, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a developer of novel drugs

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
6801 N. Capital of Texas Highway
Phone
+1 512 501-2444
Employees
29
Web
https://www.cassavasciences.com
Interact to see
Advertisement
NVIDIA’s earnings on May 28 could jolt the tech sector. With market volatility rising, traders are turning to Tickeron’s AI Agent for real-time insights, predictive analytics, and dual-strategy trading tools to navigate potential price swings and seize market opportunities.
#artificial_intelligence
As the DOJ and FTC move to break up Google’s search dominance and impose AI investment oversight, the tech giant faces a pivotal legal battle that could reshape the digital and AI landscapes—creating major implications for investors, competitors, and consumers alike.
#artificial_intelligence
GameStop (GME) continues to captivate investors with its explosive volatility and strong retail sentiment. As AI tools highlight bullish signals and a possible breakout, traders weigh the risks of speculation against the potential rewards in May 2025.
#artificial_intelligence
Mastercard (MA) continues to impress investors with strong earnings, rising digital payments, and bullish AI-driven signals. Backed by robust financials and cutting-edge trading tools from Tickeron, MA stands out as a leader in the fintech space for 2025.
From Walmart's retail resilience to Exxon Mobil's energy strength, May 2025 highlights key market movers. Discover how Tickeron’s AI bots analyze WMT, IVW, COST, and XOM—uncovering trends, boosting trading strategies, and navigating market volatility with precision.
#trading#artificial_intelligence
A powerful recession signal is flashing red: the Leading/Lagging Ratio has plunged to levels not seen since 2008. As markets grow turbulent, smart investors are turning to Tickeron’s AI trading agents to spot opportunities and stay ahead of the downturn.
#trading#artificial_intelligence
AI trading bots are no longer just experimental—they’re outperforming traditional strategies. Discover how bots trading ITA, TSM, META, and others achieved over 40% annual returns and what this means for the future of investing.
FingerMotion (FNGR) is making waves in 2025 with a 52% stock surge, strategic AI expansion into Indonesia, and strong retail momentum. Learn how traders are using correlation analysis, inverse ETFs, and Tickeron’s AI tools to navigate FNGR’s dynamic moves.
#artificial_intelligence#trading
Ferrari (RACE) is accelerating in 2025 with a 25% YTD gain, strong earnings, and bullish momentum fueled by innovation and Lewis Hamilton’s F1 move. Discover how Tickeron’s AI tools help traders capitalize on this luxury stock’s high-performance potential.
Intel’s stock is down 64%, but a bold turnaround under new CEO Lip-Bu Tan and the upcoming 18A chip rollout could spark a rebound. This article explores Intel’s financials, strategic shifts, and how AI tools from Tickeron help traders navigate the volatility.
#artificial_intelligence
Dogecoin (DOGE) fell 12.78% in five days, rattled by whale activity, Musk headlines, and ETF rumors. Is a breakout coming—or more downside? Explore key trends, technical levels, and how Tickeron’s AI bots help traders navigate DOGE’s next move.
The week of June 2-6, 2025, saw financial markets demonstrate resilience amid U.S.-China trade tensions and key economic data releases.
Tesla, Inc. (TSLA), a global leader in electric vehicles (EVs) and artificial intelligence (AI)-driven technologies, has been a focal point for investors in 2025.
#artificial_intelligence#trading
As artificial intelligence continues to reshape the financial industry, AI-powered trading agents have emerged as influential tools in portfolio management and speculative trading.
#investment#artificial_intelligence
Amazon (NASDAQ: AMZN) remains a cornerstone of the technology and e-commerce sectors, consistently driving innovation and market influence.
#artificial_intelligence
ntroduction to Eli Lilly and Company (LLY) Eli Lilly and Company (LLY), a global pharmaceutical giant, has been a cornerstone of the healthcare sector since its founding in 1876. Headquartered in Indianapolis, Indiana, the company specializes in developing innovative treatments for diabetes, oncology, immunology, and neuroscience, with blockbuster drugs like Mounjaro and Zepbound driving significant…
Tickeron, a leader in AI-driven financial solutions, announces the launch of its latest AI trading robot designed for five high-profile stocks: Amazon.com, Inc. (AMZN), Taiwan Semiconductor Manufacturing Company, Ltd. (TSM), Walmart Inc. (WMT), Google LLC (GOOG), and Meta Platforms Inc. (META).
MicroAlgo Inc. ($MLGO), a company focused on developing advanced algorithms and AI-driven solutions, has garnered attention in the financial markets due to its volatile price movements and potential for significant upside.
Tickeron, a leader in AI-driven financial solutions, proudly announces the exceptional performance of its XAR AI Trading Agent, achieving a remarkable +62% return and an 84.16% profitable trade rate for the SPDR S&P Aerospace & Defense ETF (XAR).
#artificial_intelligence#trading
The week of June 9-13, 2025, was characterized by significant market volatility driven by both positive developments in US-China trade relations and escalating geopolitical tensions in the Middle East.